Wyeth Seeks To Consolidate Protonix Patent Cases
This article was originally published in The Pink Sheet Daily
Teva, Sun Pharmaceutical and Schwarz Pharma targeted in lawsuits involving the proton pump inhibitor.
You may also be interested in...
Final ANDA approval of Teva's and Sun’s generic versions of the proton pump inhibitor are anticipated in August and September, respectively.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13